AgenDix

AgenDix GmbH was a German molecular diagnostics company based in Wiesbaden that specialized in molecular pathology and personalized medicine. The company focused on the development and distribution of advanced diagnostic tests for oncology, particularly in the field of urology. AgenDix was a prominent distributor of the UroVysion Bladder Cancer Kit, a fluorescence in situ hybridization (FISH) assay used for the detection of chromosomal abnormalities. The company provided comprehensive services to pathological institutes and clinics, facilitating the integration of molecular markers into routine clinical practice. Beyond distribution, AgenDix aimed to advance the field of personalized oncology through the identification of prognostic and predictive biomarkers. The company is currently inactive, having been liquidated and removed from the commercial register in 2016.